Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synergy Pharmaceuticals Inc.

www.synergypharma.com

Latest From Synergy Pharmaceuticals Inc.

Keeping Track: Shutdown Edition

The latest drug development news and highlights from our US FDA Performance Tracker.

Drug Review Regulation

Pipeline Watch: Top-Line Data For Reslizumab, Erenumab And Biosimilar Rituximab

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Deals Shaping The Medical Industry, December 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance or Financing. This month’s column covers deals announced in November 2017.

Deals BioPharmaceutical

Finance Watch: A Bountiful November Harvest For Venture-Backed Biopharma

Five funds raised more than $1bn to back biotech firms; Arcus leads recent VC rounds with $107m GV-backed Series C; Celgene, Valeant sell notes to retire debt; and Alnylam cashes in on investor goodwill.

Financing Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Synergy Pharmaceuticals Inc.
  • Senior Management
  • Gary S Jacob, PhD, CEO
    Gary G Gemignani, EVP, CFO
    Patrick H Griggin, MD, EVP, CMO
    Marino Garcia, EVP, Chief Strategy Officer
    Troy Hamilton, EVP, Chief Commercial Officer
  • Contact Info
  • Synergy Pharmaceuticals Inc.
    Phone: (212) 297-0020
    420 Lexington Ave., Ste. 2012
    New York, NY 10170
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register